Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Boston Scientific Corp., consolidated balance sheet: assets (quarterly data)

US$ in millions

	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018
Cash and cash equivalents	570)	928)	338)	276)	325)	1,925)	1,947)	2,675)	2,016)	1,734)	2,022)	1,724)	370)	217)	277)	123)	139)	146)	168)	208)	287)
Trade accounts receivable, net	2,076)	1,970)	1,871)	1,917)	1,866)	1,778)	1,669)	1,675)	1,631)	1,531)	1,598)	1,457)	1,577)	1,828)	1,796)	1,712)	1,621)	1,608)	1,580)	1,587)	1,580)
Inventories	2,050)	1,867)	1,788)	1,752)	1,736)	1,610)	1,603)	1,430)	1,407)	1,351)	1,472)	1,516)	1,628)	1,579)	1,566)	1,300)	1,228)	1,166)	1,134)	1,087)	1,113)
Prepaid income taxes	296)	264)	262)	264)	249)	205)	217)	202)	192)	194)	174)	181)	205)	195)	189)	175)	163)	161)	43)	46)	50)
Assets held for sale	—)	—)	—)	—)	—)	—)	—)	—)	—)	1,133)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Other current assets	712)	731)	885)	874)	889)	799)	793)	776)	855)	751)	894)	925)	1,043)	880)	1,019)	3,024)	3,083)	922)	1,046)	1,001)	1,050)
Current assets	5,704)	5,760)	5,144)	5,083)	5,065)	6,317)	6,229)	6,758)	6,101)	6,694)	6,160)	5,803)	4,823)	4,699)	4,847)	6,334)	6,234)	4,003)	3,971)	3,929)	4,080)
Property, plant and equipment, net	2,478)	2,446)	2,273)	2,246)	2,265)	2,252)	2,109)	2,082)	2,053)	2,084)	2,064)	2,079)	2,098)	2,079)	1,942)	1,820)	1,782)	1,782)	1,730)	1,715)	1,700)
Goodwill	13,269)	12,920)	12,852)	12,883)	12,949)	11,988)	11,820)	10,874)	10,868)	9,951)	10,137)	10,101)	10,098)	10,176)	10,015)	8,451)	8,179)	7,911)	7,588)	7,242)	6,984)
Other intangible assets, net	6,060)	5,902)	6,058)	6,349)	6,581)	6,121)	6,227)	5,788)	5,991)	5,917)	6,797)	7,160)	7,393)	7,886)	8,074)	6,486)	6,448)	6,372)	6,297)	5,934)	5,713)
Deferred tax assets	3,900)	3,942)	4,018)	4,059)	4,102)	4,142)	4,049)	4,036)	4,173)	4,210)	4,172)	4,182)	4,162)	4,196)	—)	—)	—)	—)	—)	—)	—)
Other long-term assets	1,481)	1,499)	1,602)	1,569)	1,375)	1,409)	1,443)	1,630)	1,714)	1,921)	1,515)	1,498)	1,539)	1,529)	1,878)	1,218)	1,159)	931)	793)	795)	725)
Long-term assets	27,188)	26,709)	26,803)	27,106)	27,272)	25,912)	25,648)	24,410)	24,799)	24,083)	24,685)	25,020)	25,290)	25,866)	21,909)	17,975)	17,568)	16,996)	16,408)	15,686)	15,122)
Total assets	32,892)	32,469)	31,947)	32,189)	32,337)	32,229)	31,877)	31,168)	30,900)	30,777)	30,845)	30,823)	30,113)	30,565)	26,756)	24,309)	23,802)	20,999)	20,379)	19,615)	19,202)

Cash and cash equivalents: There is notable volatility in cash and cash equivalents over the reported quarters. Beginning at $287 million in March 2018, the balance declined to a low near $123 million in mid-2019, followed by a significant increase peaking at $2,675 million in March 2021. Afterward, a sharp decrease occurred, with amounts dropping below $300 million in early 2022, before moderately recovering to $570 million by March 2023.
Trade accounts receivable, net: Trade receivables showed gradual growth overall, rising from $1,580 million in March 2018 to $2,076 million by March 2023. There are small fluctuations, but the trend is consistently upward, indicating growth in sales on credit or extended payment terms over the period.
Inventories: Inventory levels increased steadily, rising from $1,113 million at the start of the period to $2,050 million in March 2023. This continuous accumulation suggests increased stockholding, potentially due to higher sales volumes or stockpiling strategies.
Prepaid income taxes: Prepaid income taxes fluctuated moderately, increasing from $50 million initially to a general range between $190 million and $300 million in later periods. There was a notable jump in late 2018 to early 2019, stabilizing afterward at higher levels.
Assets held for sale: A single significant amount of $1,133 million appeared in December 2020, indicating disposal or planned disposal of assets during that quarter. No other amounts were reported thereafter.
Other current assets: Other current assets experienced considerable fluctuation. A substantial spike occurred in early 2019 reaching over $3 billion, followed by a sharp decline back to levels around $700-$900 million from 2020 onward, implying a one-time event or reclassification affecting that period.
Current assets: Current assets increased markedly from $4,080 million in March 2018 to peaks above $6,700 million in late 2020. Subsequently, they reverted to around the $5,700 million range by early 2023. The rise corresponds with the increase in cash and several other current asset components, reflecting greater liquidity and short-term resource accumulation followed by normalization.
Property, plant and equipment, net: This asset category grew steadily, with values rising from $1,700 million in March 2018 to $2,478 million by March 2023, indicating ongoing investment in fixed assets and infrastructure expansion.
Goodwill: Goodwill balances consistently increased over the period, from $6,984 million to $13,269 million. This pattern suggests significant acquisition activity or reassessment of intangible asset values, nearly doubling the initial amount over five years.
Other intangible assets, net: Other intangible assets peaked around $8,000 million in 2019 before gradually declining to about $6,000 million by March 2023. This decrease may reflect amortization, impairments, or disposals of intangible assets over time.
Deferred tax assets: Deferred tax assets are reported from late 2019, remaining relatively stable between approximately $3,900 million and $4,200 million, showing minor fluctuations but maintaining a steady asset base in this classification.
Other long-term assets: Other long-term assets varied around the $1,400 to $1,900 million range, showing fluctuations without a strong directional trend, possibly reflecting reclassifications or changes in valuation.
Long-term assets: Long-term assets increased considerably from $15,122 million to peak near $27,272 million by early 2022, followed by a slight decline and stabilization around $27,000 million through early 2023. This overall growth indicates significant capital investment and asset base expansion over the period.
Total assets: Total assets exhibited steady growth from $19,202 million in March 2018 to $32,892 million in March 2023, demonstrating consistent asset accumulation and balance sheet expansion driven by increases in both current and long-term asset categories.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

Boston Scientific Corp. (NYSE:BSX)

Balance Sheet: Assets Quarterly Data

Assets: Selected Items

Current Assets: Selected Items

Balance Sheet: Assets
Quarterly Data